Atsuko Arisawa
Overview
Explore the profile of Atsuko Arisawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
109
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kuroda H, Okita Y, Arisawa A, Utsugi R, Murakami K, Hirayama R, et al.
PLoS One
. 2025 Jan;
20(1):e0316168.
PMID: 39792964
Background: Glioblastoma is characterized by neovascularization and diffuse infiltration into the adjacent tissue. T2*-based dynamic susceptibility contrast (DSC) MR perfusion images provide useful measurements of the biomarkers associated with tumor...
2.
Chida D, Okita Y, Utsugi R, Kuroda H, Hirayama R, Kijima N, et al.
Oncol Lett
. 2024 Nov;
28(6):610.
PMID: 39493435
O6-methylguanine DNA methyltransferase promoter methylation is an important clinical biomarker of newly diagnosed glioblastoma. Previous radiological studies using dynamic susceptibility contrast (DSC) magnetic resonance imaging (MRI) perfusion have aimed to...
3.
Takahashi H, Takami Y, Takeda S, Hayakawa N, Nakajima T, Takeya Y, et al.
AJNR Am J Neuroradiol
. 2024 Feb;
45(3):320-327.
PMID: 38331963
Background And Purpose: Biomarkers have been required for diagnosing early Alzheimer disease. We assessed the utility of hippocampal diffusion parameters for diagnosing Alzheimer disease pathology in mild cognitive impairment. Materials...
4.
Yamamoto S, Okita Y, Arita H, Sanada T, Sakai M, Arisawa A, et al.
J Neurooncol
. 2023 Nov;
165(2):251-259.
PMID: 37917281
Purpose: To identify qualitative MRI features of non-(contrast)-enhancing tumor (nCET) in glioblastoma's T2-FLAIR hyperintense lesion. Methods: Thirty-three histologically confirmed glioblastoma patients whose T1-, T2- and contrast-enhanced T1-weighted MRI and C-methionine...
5.
Haji S, Fujita K, Oki R, Osaki Y, Miyamoto R, Morino H, et al.
JMIR Res Protoc
. 2023 Jan;
12:e42032.
PMID: 36716091
Background: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder, with its currently approved drugs, including riluzole and edaravone, showing limited therapeutic effects. Therefore, safe and effective drugs are urgently...
6.
Fujita Y, Khoo H, Hirayama M, Kawahara M, Koyama Y, Tarewaki H, et al.
Front Neurosci
. 2022 Jul;
16:921922.
PMID: 35812224
Background: The unsurpassed sensitivity of intracranial electroencephalography (icEEG) and the growing interest in understanding human brain networks and ongoing activities in health and disease have make the simultaneous icEEG and...
7.
Yamamoto S, Sanada T, Sakai M, Arisawa A, Kagawa N, Shimosegawa E, et al.
Brain Sci
. 2022 Jan;
12(1).
PMID: 35053842
One of the challenges in glioblastoma (GBM) imaging is to visualize non-enhancing tumor (NET) lesions. The ratio of T1- and T2-weighted images (rT1/T2) is reported as a helpful imaging surrogate...
8.
Takahashi H, Kashiwagi N, Arisawa A, Matsuo C, Kato H, Adachi H, et al.
Br J Radiol
. 2021 Nov;
95(1130):20210837.
PMID: 34808066
Objective: To assess the utility of examining the nigrostriatal system with MRI and dopamine transporter (DAT) imaging for evaluating the preclinical phase of Parkinson's disease (PD). Methods: The subjects were...
9.
Sakisuka T, Kashiwagi N, Doi H, Takahashi H, Arisawa A, Matsuo C, et al.
Mol Clin Oncol
. 2021 Oct;
15(5):246.
PMID: 34650813
Although bone is the second-most frequent site of distant metastases of head and neck squamous cell carcinoma (HNSCC), variable prognostic factors in patients with bone metastases from HNSCC have not...
10.
Asai K, Nakamura H, Watanabe Y, Nishida T, Sakai M, Arisawa A, et al.
J Neurointerv Surg
. 2021 Mar;
13(12):1167-1171.
PMID: 33722964
Background: In preoperative embolization for intracranial meningioma, endovascular intratumoral embolization is considered to be more effective for the reduction of tumorous vascularity than proximal feeder occlusion. In this study, we...